Randomized Phase II Trial Of Sequential ATRA Then IL-2 For Modulation Of Dendritic Cells And Treatment Of Metastatic Renal Cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Tretinoin (Primary) ; Interleukin-2
- Indications Renal cancer
- Focus Therapeutic Use
- 16 Aug 2013 Biomarkers information updated
- 11 Jul 2013 Planned end date changed from 1 Sep 2013 to 1 Jan 2014 as reported by ClinicalTrials.gov.
- 01 Jul 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.